4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-077664
Options or other derivatives
- Director acquired 1,462,927 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| MOTT DAVID M Director | 2023-07-03 | Grant or award · Option to purchase Ordinary Shares | +1,462,927 | 1,462,927 | D | ||
Loading xslF345X04/tm2320409-2_4seq1.xml…